06.08.2024 15:32 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
22.07.2024 14:33 | TSTL | Tristel reports double-digit revenue growth ahead of targets | Alliance |
22.07.2024 07:00 | TSTL | Trading Update | RNS |
04.07.2024 15:43 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
11.06.2024 21:52 | TSTL | IN BRIEF: Tristel CEO Swinney and CFO Dixon offload shares | Alliance |
11.06.2024 17:48 | TSTL | Director/PDMR Shareholding | RNS |
11.06.2024 15:50 | TSTL | Holding(s) in Company | RNS |
10.06.2024 09:17 | TSTL | Tristel hires former Lidco CEO to replace founder Paul Swinney at helm | Alliance |
10.06.2024 07:00 | TSTL | Appointment of CEO | RNS |
08.05.2024 07:00 | TSTL | Tristel™ ULT case study | Reach |
07.05.2024 09:51 | AIBG, BIRG, S32 | LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered | Alliance |
07.05.2024 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
18.04.2024 12:42 | TSTL | IN BRIEF: Tristel CEO Paul Swinney sells GBP230,000 in shares | Alliance |
16.04.2024 14:04 | TSTL | Director/PDMR Shareholding | RNS |
15.04.2024 17:56 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
05.04.2024 13:52 | TSTL, LPA, LAND | UK dividends calendar - next 7 days | Alliance |
19.03.2024 09:25 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
14.03.2024 15:06 | VSL, TSTL, TENT | UK dividends calendar - next 7 days | Alliance |
27.02.2024 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
26.02.2024 09:50 | TSTL | Tristel doubles dividend on revenue and profit boost in first half | Alliance |
26.02.2024 07:01 | TSTL | Half-year Report | RNS |
26.02.2024 07:00 | TSTL | UK and EU regulatory approval update | RNS |
19.02.2024 12:53 | TSTL, MTEC, KOS | UK earnings, trading statements calendar - next 7 days | Alliance |
08.02.2024 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
25.01.2024 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
23.01.2024 13:22 | TSTL | Tristel gets approval in Canada for ULT ultrasound disinfectant device | Alliance |
23.01.2024 07:00 | TSTL | Canadian regulatory approval for Tristel ULT | RNS |
10.01.2024 14:27 | TSTL | Director/PDMR Shareholding | RNS |
19.12.2023 12:02 | TSTL | Result of AGM | RNS |
19.12.2023 11:47 | TSTL | Tristel optimistic of strong second half following good start to year | Alliance |
19.12.2023 07:00 | TSTL | AGM Statement | RNS |
15.12.2023 15:58 | TSTL, SEIT, SREI | UK dividends calendar - next 7 days | Alliance |
07.12.2023 14:05 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
01.12.2023 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
29.11.2023 12:40 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
07.11.2023 11:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
16.10.2023 10:06 | TSTL | Tristel's annual profit multiplies; outlook "strongest" in 30 years | Alliance |
16.10.2023 07:00 | TSTL | Audited Preliminary Results | RNS |
12.10.2023 07:00 | TSTL | Additional Investor Presentation | Reach |
10.10.2023 16:45 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
09.10.2023 15:45 | TSTL, SEE | UK earnings, trading statements calendar - next 7 days | Alliance |
02.10.2023 11:50 | TSTL | Holding(s) in Company | RNS |
28.09.2023 14:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
26.09.2023 14:40 | AV., TSTL | Holding(s) in Company | RNS |
25.09.2023 08:40 | TSTL | Holding(s) in Company | RNS |
22.09.2023 15:40 | AV., TSTL | Holding(s) in Company | RNS |
12.09.2023 07:00 | TSTL | Notice of Results | RNS |
04.09.2023 14:07 | TSTL | Tristel submits to Health Canada for Tristel ULT medical approval | Alliance |
04.09.2023 07:00 | TSTL | Health Canada regulatory approval submission | Reach |
15.08.2023 09:28 | TSTL, PFC, BWY | LONDON BROKER RATINGS: Liberum starts Tristel with 'hold' | Alliance |
31.07.2023 08:05 | TSTL | Holding(s) in Company | RNS |
28.07.2023 14:17 | TSTL | IN BRIEF: Tristel CEO Paul Swinney sells GBP350,000 in shares | Alliance |
28.07.2023 08:28 | TSTL | Director/PDMR Shareholding | RNS |
25.07.2023 10:56 | TSTL | Tristel annual revenue and profit up thanks to robust demand | Alliance |
25.07.2023 07:00 | TSTL | Trading update | RNS |
18.07.2023 15:43 | UTG, ULVR, TSTL | UK earnings, trading statements calendar - next 7 days | Alliance |
12.07.2023 07:00 | TSTL | Shareholder Open Day and Notice of Trading Update | RNS |
10.07.2023 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
26.06.2023 07:00 | TSTL | Director/PDMR Shareholding | RNS |
22.06.2023 16:01 | AV., TSTL | Holding(s) in Company | RNS |
16.06.2023 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
14.06.2023 16:10 | AV., TSTL | Holding(s) in Company | RNS |
06.06.2023 17:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
05.06.2023 10:26 | TSTL, DXRX, BBB | AIM WINNERS & LOSERS: Tristel hails FDA approval of ULT disinfectant | Alliance |
05.06.2023 10:24 | TSTL | Tristel shares soar amid US FDA approval for ultrasound disinfectant | Alliance |
05.06.2023 10:00 | TSTL | Analyst and Investor presentation | RNS |
05.06.2023 07:00 | TSTL | FDA De Novo approval | RNS |
25.05.2023 09:23 | TSTL, AGR, PHP | LONDON BROKER RATINGS: Numis starts Tristel with 'add' | Alliance |
28.03.2023 11:30 | TSTL | Issue of Equity | RNS |
27.03.2023 18:42 | NFX, TSTL, AGY | TRADING UPDATES: Sabien works with Empiric; Coro sells in Italy | Alliance |
27.03.2023 07:00 | TSTL | Successful submission of additional data to US FDA | RNS |
14.03.2023 14:05 | TSTL | Second Price Monitoring Extn | RNS |
14.03.2023 14:00 | TSTL | Price Monitoring Extension | RNS |
14.03.2023 09:30 | TSTL | Issue of Equity | RNS |
22.02.2023 16:30 | TSTL | Issue of Equity | RNS |